ERBB2 and hypoparathyroidism-retardation-dysmorphism syndrome: Both amplification of the human epidermal growth factor receptor 2 (Her-2/Neu) and homologous recombination deficiency (HRd) are frequent molecular alterations in this subclass [14••, 17•, 37•].